Recovery Modalities
Bayer Moves Hyrnuo Into Frontline Lung Cancer
Bayer secured FDA approval for Hyrnuo lung cancer treatment, marking a major shift in frontline HER2-mutant NSCLC care based on new clinical data.
By Samoyed · Sep 10, 2026
Category: Recovery Modalities
Recovery Modalities
Sensorion gets green light for HearConnex trial
Sensorion's HearConnex trial gets green light for hearing loss treatment with gene therapy SENS-601.
By Samoyed · Sep 4, 2026
Recovery Modalities
HiRO and Differentia Biotech collaborate on trial simulation
HiRO and Differentia Biotech collaborate on advanced clinical trial simulation models. Learn how this AI-driven partnership aims to support biopharmaceutical sp
By emily johnson · Aug 31, 2026
Recovery Modalities
Daiichi Sankyo Begins Phase I DS1025 Trial
First patient dosing has begun in the Phase I DS1025 study , a trial that will assess an investigational antibody‑drug conjugate in adults with advanced.
By Samoyed · Aug 29, 2026